A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Neovascular Age-Related Macular Degeneration
Related studies linked through entity extraction aliases.
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Status
- RECRUITING
- Phase
- PHASE3
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
- Status
- RECRUITING
- Phase
- PHASE3
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
- Status
- RECRUITING
- Phase
- PHASE4
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study for the Port Delivery System With Ranibizumab (Portal)
- Status
- RECRUITING
- Phase
- PHASE3